Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mamoon, Aldeyab"'
Autor:
Geraldine Mary Conlon-Bingham, Mamoon Aldeyab, Michael Scott, Mary Patricia Kearney, David Farren, Fiona Gilmore, James McElnay
Publikováno v:
Emerging Infectious Diseases, Vol 25, Iss 1, Pp 52-62 (2019)
This quasi-experimental study investigated the effect of an antibiotic cycling policy based on time-series analysis of epidemiologic data, which identified antimicrobial drugs and time periods for restriction. Cyclical restrictions of amoxicillin/cla
Externí odkaz:
https://doaj.org/article/e802e9f86e4446e5ae6fa6107e90e3ea
Publikováno v:
British journal of clinical pharmacologyREFERENCES.
Infliximab is a tumour necrosis factor-alpha inhibitor that is used to treat children with refractory Kawasaki disease (KD). Our purpose was to evaluate the safety and impact of infliximab versus intravenous immunoglobulins on the incidence of corona
Autor:
Elena Alba, Álvaro-Alonso, Mamoon, Aldeyab, Linden, Ashfield, Fiona, Gilmore, Montserrat, Pérez-Encinas
Publikováno v:
Farmacia Hospitalaria, Vol 40, Iss 5, Pp 233-236 (2016)
Farmacia Hospitalaria v.40 n.4 2016
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Farmacia Hospitalaria v.40 n.4 2016
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Autor:
José-María, López-Lozano, Timothy, Lawes, César, Nebot, Arielle, Beyaert, Xavier, Bertrand, Didier, Hocquet, Mamoon, Aldeyab, Michael, Scott, Geraldine, Conlon-Bingham, David, Farren, Gábor, Kardos, Adina, Fésűs, Jesús, Rodríguez-Baño, Pilar, Retamar, Nieves, Gonzalo-Jiménez, Ian M, Gould, Hajnalka, Tóth
Publikováno v:
Nature microbiology. 4(7)
Balancing access to antibiotics with the control of antibiotic resistance is a global public health priority. At present, antibiotic stewardship is informed by a 'use it and lose it' principle, in which antibiotic use by the population is linearly re